CLX-0940

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameCLX-0940

Drug Alias NameCLX-0940

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPeroxisome proliferator-activated receptor γ inhibitorsInsulin sensitizersPeroxisome proliferator-activated receptor delta agonists +[4]

TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor deltaPeroxisome proliferator-activated receptor α

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCalyx Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCalyx Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A